Improving neuroprotective effects of resveratrol by brain targeting through chitosan glutamate nanoparticles in MPTP induced parkinsonism
Objective: The aim of the present study was to develop and evaluate the neuroprotective effects of resveratrol (RV) using chitosan glutamate nanoparticles (RV-CG-NPs) in a…Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features
Objective: We aim to study video-polysomnography (VPSG) and clinical features in patients with MSA. First, we investigate whether VPSG findings differ depending on the presence…Concentration of short chain fatty acids in the peripheral blood of patients with Parkinson disease
Objective: Based on the possible role of short chain fatty acids (SCFAs) on the permeability of the blood-brain barrier and its change in Parkinson disease…Frailty in Parkinson’s disease: A systematic review
Objective: The aim of this study was to examine the co-occurrence of frailty in people with PD; to describe the measures used to assess frailty…The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson’s disease: a 3-month open-label study
Objective: To investigate the effect of zonisamide (ZNS) on motor and non-motor symptoms, such as depressive symptoms and sleep problems, in patients with Parkinson’s disease…Clinical comparison of right onset PD vs left onset PD
Objective: To compare clinical characteristics in right side onset versus left side onset of Parkinson’s disease and evaluate whether side of onset was predictive of…Rare manifestation of CNS Lupus: Parkinsonism
Objective: To describe clinical and imaging features of a SLE patient who presented with parkinsonism which is a rare manifestation of NPSLE and the result…Predicting domain specific cognitive impairment in Parkinson’s disease
Objective: To investigate whether between-hippocampal connectivity and CSF proteins can predict domain-specific cognitive impairment in Parkinson’s disease (PD). Background: Cognitive dysfunction is a common and…Movement disorders associated with intracranial and extracranial artery diseases
Objective: To investigate the characteristics and prognosis of movement disorders caused by intracranial and extracranial artery diseases. Background: Intracranial and extracranial artery diseases may cause…Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.
Objective: To assess the feasibility of developing a patient-reported Botulinum Toxin Response Scale (BTRS) for different neurological conditions. Background: Botulinum toxin (BoNT) is a highly…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 217
- Next Page »